Related Experiment Videos
Linking gene expression data with patient survival times using partial least squares
Peter J Park1, Lu Tian, Isaac S Kohane
1Children's Hospital Informatics Program and Harvard Medical School, 300 Longwood Ave, Boston, MA 02115, USA. peter_park@harvard.edu
Bioinformatics (Oxford, England)
|August 10, 2002
Summary
This study introduces a novel Poisson regression approach to analyze patient survival data, effectively handling censored data. The method integrates partial least squares and generalized linear regression for robust genotypic and phenotypic data analysis.
Area of Science:
- Bioinformatics
- Biostatistics
- Genomics
Background:
- Integrating genotypic and phenotypic data is crucial for patient stratification.
- Analyzing patient survival data with censoring presents significant statistical challenges.
- Existing methods often do not fully leverage complex genotypic data for survival analysis.
Purpose of the Study:
- To develop a robust statistical method for analyzing patient survival data with censored outcomes.
- To effectively link high-dimensional genotypic data with phenotypic information, specifically survival times.
- To address the limitations of traditional regression models when dealing with censored survival data.
Main Methods:
- Reformulation of survival analysis with censored data into a Poisson regression problem.
- Integration of Partial Least Squares (PLS) for handling high-dimensional, collinear genotypic data.
- Application of Generalized Linear Regression (GLR) to accommodate various response variable types, including survival times.
Main Results:
- The proposed method successfully circumvents issues associated with censored data.
- Identified linear combinations of variables correlate strongly with patient survival times while accounting for covariate variability.
- The algorithm demonstrates computational efficiency, avoiding matrix decompositions during iterations.
Conclusions:
- The combined PLS and GLR approach offers an effective solution for analyzing censored survival data in the presence of large genotypic datasets.
- This method provides a valuable tool for linking genetic information with patient outcomes, applicable to various cancer studies.
- The algorithm's speed and effectiveness were validated on lung carcinoma and diffuse large B-cell lymphoma datasets.